Cell line · CVCL_0093
RS4;11
Cancer cell line, Homo sapiens. Adult B acute lymphoblastic leukemia. 53 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. RS4;11. Cell lines, record CVCL_0093. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0093
On this page
Cell line
As Cellosaurus gives it.
- Name
- RS4;11
- Accession
- CVCL_0093
- RRID
- RRID:CVCL_0093
- Synonyms
- RS4-11, RS4:11, RS 4;11, RS(4;11), RS411
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- 32Y
- Category
- Cancer cell line
- Diseases
Adult B acute lymphoblastic leukemia (NCIt C9143); B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged (NCIt C80342); B-lymphoblastic leukemia/lymphoma with t(v;11q23.3) (ORDO Orphanet_585918)
- Derived from
- Bone marrow (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2025-08-14
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers53
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Development of CAR T Cells Targeting a Surface RNA-Binding Protein for the Treatment of Acute Leukemias. | Cancer Discov | 2026 | Its Methods give the RRID and name the line | PubMed | |
| BCR::ABL1-Induced Enhancer Reprogramming Uncovers Hypersensitivity of Ph+B-ALL Cells to Enhancer-Targeting Drugs. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| RBM15B recognizes H3K79me2 to guide selective m6A-modification of mRNA and enhance oncoprotein translation in MLL-r leukemia. | EMBO J | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Chronic ER Stress Triggers Cell-Surface Chaperones as the Therapeutic Targets of CAR Cells in Acute Myeloid Leukemia. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Highly specific Immunoproteasome inhibitor M3258 induces proteotoxic stress and apoptosis in KMT2A::AFF1 driven acute lymphoblastic leukemia. | Sci Rep | 2025 | Its Methods give the RRID and name the line | PubMed | |
| GREM1 deficiency induced bone marrow adipose niche promotes B-cell acute lymphoblastic leukemia disease progression. | Int J Cancer | 2025 | Its Methods give the RRID and name the line | PubMed | |
| PLK1 Inhibition Induces Synthetic Lethality in Fanconi Anemia Pathway-Deficient Acute Myeloid Leukemia. | Cancer Res Commun | 2025 | Its Methods give the RRID and name the line | PubMed | |
| KMT2A degradation is observed in decitabine-responsive acute lymphoblastic leukemia cells. | Mol Oncol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Novel immunotherapeutics against LGR5 to target multiple cancer types. | EMBO Mol Med | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Comparable efficacy of oral bendamustine versus intravenous administration in treating hematologic malignancies. | Cancer Chemother Pharmacol | 2024 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 53
See all 53 papersRelatives3
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | RS4;11 BCL2-F104L | CVCL_XZ61 | Cell lines | |
| Derived from it | RS4;11 BCL2-G101V | CVCL_XZ62 | Cell lines | |
| Derived from it | RS4;11 mouse MCL1 | CVCL_E8JJ | Cell lines |
Cell banks4
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | CRL-1873 | ATCC | |
| AddexBio | C0003012/4671 | Cellosaurus | |
| CLS | 305360 | CLS | |
| DSMZ | ACC-508 | DSMZ |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0093
GET https://conductscience.org/api/cell-lines/v1/CVCL_0093/papers?page=2